<DOC>
	<DOCNO>NCT01733680</DOCNO>
	<brief_summary>The investigator propose test medication derive prior study gene SLC9A9 . This one gene make NHE protein control learn remember item , impair ADHD may cause inability plan , prioritize , self-monitor , inhibit , initiate , self-correct , control one 's behavior . The investigator propose investigate therapeutic utility NHE inhibitor , amiloride hydrochloride , treatment attention deficit hyperactivity disorder ( ADHD ) medication-naïve adult ADHD .</brief_summary>
	<brief_title>Amiloride Hydrochloride Effective Treatment ADHD</brief_title>
	<detailed_description>Our specific aim hypothesis follow : Primary Aim : Assess efficacy adverse effect amiloride medication naive ADHD adult placebo control study . Hypothesis 1 : Amiloride reduce score primary outcome measure , Adult Attention-Deficit/Hyperactivity Disorder Investigator Symptom Rating Scale ( AISRS ) secondary outcome , ADHD specific Clinical Global Impressions ( CGI ) improvement scale . Hypothesis 2 : Amiloride well tolerated side effect adults ADHD . Exploratory Aim 2 : Assess effect amiloride ADHD-associated clinical feature . We also assess , exploratory manner , effect amiloride two clinical feature well treat current ADHD medication : deficit emotional self-regulation ( DESR ) executive function deficit ( EFD ) . Hypothesis 3 predicts amiloride treatment reduce symptom DESR EFD . We recruit 40 adult diagnose ADHD double blind placebo control study . 20 subject receive amiloride hydrochloride 20 subject receive placebo 8 week . Participation study require subject meet physician screen visit , baseline visit 8 additional weekly visit .</detailed_description>
	<mesh_term>Amiloride</mesh_term>
	<criteria>1 . Medication naïve male female adult age 1855 year . 2 . A diagnosis DSMIV ADHD combine type base clinical assessment study psychiatrist use Conners Adult ADHD Diagnostic Interview ; 3. proficiency English ; 4 . A baseline score 24 AISRS ; 5. ability swallow pill ; 6. ability report reliably , understand nature study sign inform consent document determine study psychiatrist We exclude potential participant : 1. pharmacologic treatment ADHD past year ; 2. pregnant nursing ; 3. Investigators immediate family ( spouse , parent , child , grandparent , grandchild ) ; 4. serious , unstable medical illness include hepatic , renal , gastroenterological , respiratory , cardiovascular ( include ischemic heart disease ) , endocrinologic , neurologic , immunologic , hematologic disease ; 5. severe allergy multiple adverse drug reaction ; 6. current past history seizure ; 7. meet current DSMIV criterion anxiety depression illicit substance abuse prior six month ( exclusion feasible , although lifetime comorbidity ADHD disorder high , others show presence disorder time ascertainment adult ADHD study less 10 % ) ; 8. judge study psychiatrist serious suicidal risk . 9. current past diagnosis schizophrenia bipolar disorder ; 10. history hypersensitivity amiloride drug class member ; 11. history hyperkalemia , diabetes mellitus , renal disease anuria ; 12. renal impairment Cr &gt; 1.5 ; 13. take potassium supplement , aldosterone antagonist , tacrolimus ACE inhibitor .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>ADHD</keyword>
	<keyword>executive function</keyword>
	<keyword>emotional self-regulation</keyword>
</DOC>